Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
LCZ696 treatment significantly reduces LPS-induced intracellular ROS and MDA levels
CAS Number: 1384268-04-5
Formula: C59H73N5O10S
induces apoptosis in NSCLC cells
Ibandronate Sodium Catalog No.:M8787-2 LCZ696 treatment significantly reduces LPS-inducedIbandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved